Vemurafenib
Anant Sharma, Sachin R. Shah, Henrik Illum et al. · Drugs · 2012
Cited by 106 works. doi:10.2165/11640870-000000000-00000
Authors
References
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- Mutations of the BRAF gene in human cancer
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- ras oncogenes in human cancer: a review.
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
- Final Version of 2009 AJCC Melanoma Staging and Classification
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- Distinct Sets of Genetic Alterations in Melanoma
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib